Siqi Huang

Oct 30, 2024 | preprints.org | Xueqing Huang |Fang Li |Siqi Huang |Qibiao Weng

Preprint Article Version 1 This version is not peer-reviewed Version 1 : Received: 28 October 2024 / Approved: 29 October 2024 / Online: 30 October 2024 (09:45:35 CET) Hong, Y.; Huang, X.; Li, F.; Huang, S.; Weng, Q.; Fraidenraich, D.; Voiculescu, I. Data-driven Maturity Level Evaluation for Cardiomyocytes derived from Human Pluripotent Stem Cells (Invited Paper). Preprints 2024, 2024102358.

May 21, 2024 | lexology.com | Rachael Shek |Jojo Fan |Trevor Ho |Siqi Huang

In Re Simplicity & Vogue Retailing (HK) Co Ltd [2024] HKCA 299 (Simplicity; which we blogged about here), the Court of Appeal confirmed that the Court of Final Appeal’s approach in Re Guy Kwok Hung Lam [2023] HKCFA 9 (Guy Lam; see our blog post here) should apply in winding up cases involving an arbitration agreement.

Feb 28, 2024 | pubs.rsc.org | Ting Nie |Siqi Huang |Yuxin Yang

A review of the world's salt reduction policies and strategies – preparing for the upcoming year 2025 Excessive consumption of dietary sodium is a significant contributor to non-communicable diseases, including hypertension and cardiovascular disease. There is now a global consensus that regulating salt intake is among the most cost-effective measures for enhancing public health.

Feb 8, 2024 | pubs.rsc.org | Ting Nie |Siqi Huang |Yuxin Yang |Anna Hu

A review of the world's salt reduction policies and strategies – preparing for the upcoming 2025 Excessive consumption of dietary sodium is a significant contributor to noncommunicable diseases, including hypertension and cardiovascular disease. There is now a global consensus that regulating salt intake is among the most cost-effective measures for enhancing public health. More than half of countries worldwide have implemented multiple strategies to decrease salt consumption.

Sep 27, 2023 | cellandgene.com | Siqi Huang |Peter Su

Get more Cell & Gene insight with our FREE newsletter Article | September 27, 2023 By Siqi Huang and Peter Su, Novotech Due to their potential to address a variety of cancer-related conditions and the opportunity for refinement and expansion into other diseases, CAR T-cell therapies have garnered increasing attention in clinical trials on a global scale.